Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides derived from the propeptide NTSR3 and their use in the treatment of depression

Peptides derived from the propeptide NTSR3 and their use in the treatment of depression

US Patent 11220527 · Granted Jan 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Retro-inverso analogs of spadin display increased antidepressant effects2019
Retro-inverso analogs of spadin display increased antidepressant effects2019
Retro-inverso analogs of spadin display increased antidepressant effects2019
Therapy for promoting cell growth2019
Therapy for promoting cell growth2016
Peptide derived from neurotensin receptor 3 and use thereof in the treatment of 2012
Peptide derived from neurotensin receptor 3 and use thereof in the treatment of 2012
Peptide derived from neurotensin receptor 3 and use thereof in the treatment of 2012
Method for the prevention of ischemic spinal cord injury caused by aortic crossc2001